A detailed history of Israel Englander (Millennium Management LLC) transactions in United Therapeutics Corp stock. As of the latest transaction made, Millennium Management LLC holds 10,400 shares of UTHR stock, worth $3.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,400
Previous 3,900 166.67%
Holding current value
$3.88 Million
Previous $1.24 Million 200.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$311.04 - $363.55 $29.2 Million - $34.2 Million
-93,985 Reduced 91.22%
9,046 $3.24 Million
Q2 2024

Aug 14, 2024

BUY
$228.26 - $319.04 $13.5 Million - $18.9 Million
59,354 Added 135.89%
103,031 $32.8 Million
Q1 2024

May 15, 2024

SELL
$210.76 - $249.51 $15.9 Million - $18.8 Million
-75,532 Reduced 63.36%
43,677 $10 Million
Q4 2023

Feb 14, 2024

SELL
$214.88 - $256.94 $2.59 Million - $3.09 Million
-12,038 Reduced 9.17%
119,209 $26.2 Million
Q2 2023

Aug 14, 2023

SELL
$205.19 - $232.99 $26 Million - $29.5 Million
-126,594 Reduced 49.1%
131,247 $29 Million
Q1 2023

May 15, 2023

SELL
$212.99 - $276.17 $53.3 Million - $69.2 Million
-250,432 Reduced 49.27%
257,841 $57.7 Million
Q4 2022

Feb 14, 2023

SELL
$205.95 - $280.43 $15.1 Million - $20.6 Million
-73,437 Reduced 12.62%
508,273 $141 Million
Q3 2022

Nov 14, 2022

BUY
$203.3 - $244.17 $20.4 Million - $24.5 Million
100,312 Added 20.84%
581,710 $122 Million
Q2 2022

Aug 15, 2022

SELL
$174.81 - $241.14 $17.9 Million - $24.7 Million
-102,400 Reduced 17.54%
481,398 $113 Million
Q1 2022

May 16, 2022

BUY
$166.16 - $213.96 $29.4 Million - $37.8 Million
176,658 Added 43.39%
583,798 $105 Million
Q4 2021

Feb 14, 2022

BUY
$184.32 - $216.08 $7.51 Million - $8.81 Million
40,768 Added 11.13%
407,140 $88 Million
Q3 2021

Nov 15, 2021

SELL
$179.86 - $214.88 $33.6 Million - $40.1 Million
-186,767 Reduced 33.76%
366,372 $67.6 Million
Q2 2021

Aug 16, 2021

BUY
$170.47 - $211.93 $26 Million - $32.3 Million
152,287 Added 37.99%
553,139 $99.2 Million
Q1 2021

May 17, 2021

SELL
$153.94 - $174.85 $31.9 Million - $36.3 Million
-207,341 Reduced 34.09%
400,852 $67.1 Million
Q4 2020

Feb 16, 2021

BUY
$101.87 - $151.79 $13.1 Million - $19.6 Million
128,947 Added 26.91%
608,193 $92.3 Million
Q3 2020

Nov 16, 2020

BUY
$99.9 - $121.13 $2.58 Million - $3.13 Million
25,875 Added 5.71%
479,246 $48.4 Million
Q2 2020

Aug 14, 2020

SELL
$92.74 - $125.82 $36.7 Million - $49.8 Million
-396,175 Reduced 46.63%
453,371 $54.9 Million
Q1 2020

May 14, 2020

SELL
$79.39 - $115.35 $20.9 Million - $30.4 Million
-263,377 Reduced 23.67%
849,546 $80.6 Million
Q4 2019

Feb 14, 2020

SELL
$78.31 - $95.34 $44 Million - $53.6 Million
-562,199 Reduced 33.56%
1,112,923 $98 Million
Q3 2019

Nov 14, 2019

BUY
$74.85 - $85.99 $994,232 - $1.14 Million
13,283 Added 0.8%
1,675,122 $134 Million
Q2 2019

Aug 15, 2019

BUY
$76.06 - $120.81 $125 Million - $199 Million
1,644,968 Added 9750.27%
1,661,839 $130 Million
Q2 2019

Aug 14, 2019

BUY
$76.06 - $120.81 $431,868 - $685,959
5,678 Added 50.73%
16,871 $2.3 Million
Q1 2019

May 14, 2019

SELL
$107.15 - $126.84 $2.71 Million - $3.21 Million
-25,270 Reduced 69.3%
11,193 $1.31 Million
Q4 2018

Feb 14, 2019

SELL
$101.4 - $128.73 $9.61 Million - $12.2 Million
-94,789 Reduced 72.22%
36,463 $3.97 Million
Q3 2018

Nov 14, 2018

BUY
$113.81 - $129.46 $9.59 Million - $10.9 Million
84,262 Added 179.32%
131,252 $16.8 Million
Q2 2018

Aug 14, 2018

SELL
$101.14 - $118.31 $12.2 Million - $14.2 Million
-120,321 Reduced 71.91%
46,990 $5.32 Million
Q1 2018

May 15, 2018

SELL
$107.21 - $151.94 $8.51 Million - $12.1 Million
-79,423 Reduced 32.19%
167,311 $18.8 Million
Q4 2017

Feb 14, 2018

SELL
$118.58 - $151.28 $8.24 Million - $10.5 Million
-69,513 Reduced 21.98%
246,734 $36.5 Million
Q3 2017

Nov 14, 2017

BUY
$114.6 - $136.81 $36.2 Million - $43.3 Million
316,247
316,247 $37.1 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.